Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

886 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Healthcare workers perceptions in the difficult moment of the end of life and coping strategies adopted during the COVID-19 pandemic: an Italian pilot study.
Vitale E, Conte L, Dell'Aglio A, Calabrò A, Ilari F, Bardone L, Benedetto A, Caldararo C, Zacchino S, Lezzi A, Giordano M, Carvello M, Ercolani M, Lupo R. Vitale E, et al. Among authors: benedetto a. Acta Biomed. 2021 Dec 22;92(S2):e2021330. doi: 10.23750/abm.v92iS2.12090. Acta Biomed. 2021. PMID: 35037642 Free article.
Anxiety, Depression, Body Mass Index, Physical Activity in Nomophobic Italian Nurses: A Chronic Latent Inflammation?
Vitale E, Mea R, Benedetto A, Capizzello D, Zacchino S, Zaminga M, Russo M, Ingrosso F, Mazzarella C, Maria GS, Buccolieri T, Lupo R. Vitale E, et al. Among authors: benedetto a. Endocr Metab Immune Disord Drug Targets. 2023;23(11):1421-1429. doi: 10.2174/1871530323666230310152747. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 36896904
Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study.
Candido R, Nicolucci A, Larosa M, Rossi MC, Napoli R; RESTORE-G (Retrospective analysis on the therapeutic approaches after GLP-1 RA treatment in type 2 diabetes patients) Study Group. Candido R, et al. Nutr Metab Cardiovasc Dis. 2024 Mar 23:S0939-4753(24)00125-X. doi: 10.1016/j.numecd.2024.03.023. Online ahead of print. Nutr Metab Cardiovasc Dis. 2024. PMID: 38693036
TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication.
Iachettini S, Terrenato I, Porru M, Di Vito S, Rizzo A, D'Angelo C, Petti E, Dinami R, Maresca C, Di Benedetto A, Palange A, Mulè A, Santoro A, Palazzo A, Fuso P, Stoppacciaro A, Vici P, Filomeno L, Di Lisa FS, Arcuri T, Krasniqi E, Fabi A, Biroccio A, Zizza P. Iachettini S, et al. Among authors: di benedetto a. J Exp Clin Cancer Res. 2024 Mar 9;43(1):75. doi: 10.1186/s13046-024-02998-w. J Exp Clin Cancer Res. 2024. PMID: 38459559 Free PMC article.
886 results